|
gptkbp:instanceOf
|
biotechnology company
|
|
gptkbp:acquisition
|
gptkb:GlaxoSmithKline
|
|
gptkbp:focus
|
sirtuin research
|
|
gptkbp:founded
|
2004
|
|
gptkbp:founder
|
gptkb:David_Sinclair
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sirtris Pharmaceuticals
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:keyPeople
|
gptkb:Zhang_J._Zhang
gptkb:William_A._Haseltine
gptkb:Eric_J._Topol
gptkb:John_A._McKinley
gptkb:Stephen_J._Elledge
gptkb:Yoshinori_Ohsumi
gptkb:Thomas_R._Cech
gptkb:Michael_J._Fox
gptkb:David_Sinclair
gptkb:David_A._Sinclair
gptkb:Michael_A._Hellerstein
gptkb:Robert_L._Wilkins
gptkb:Zhou_J._Zhou
gptkb:Richard_A._Young
gptkb:William_G._Kaelin_Jr.
gptkb:Peter_J._Hotez
gptkb:Robert_J._Kauffman
gptkb:Christina_L._Warner
James M. McGowan
|
|
gptkbp:notableFeature
|
NAD+_metabolism
SIRT1_activators
caloric_restriction_mimetics
|
|
gptkbp:products
|
SRT501
|
|
gptkbp:researchAreas
|
diabetes
aging
neurodegenerative diseases
metabolic diseases
|
|
gptkbp:website
|
www.sirtrispharma.com
|